Core Laboratories Inc. (CLB) on GreekSoup https://greeksoup.ai/stocks/us/clb/ Every dated entry in the public record on Core Laboratories Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 30 Oct 2026 00:00:00 +0000 Core Laboratories Inc. Q3 FY2026 results: revenue $132 million, net income $5 million (from its press release)https://greeksoup.ai/stocks/us/clb/results/fy2026-q3/us:CLB:result:2026-10-28:b4510dcde8Wed, 28 Oct 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Core Laboratories Inc. filed 8-K: results of operations, regulation fd disclosurehttps://greeksoup.ai/stocks/us/clb/filings/us:CLB:filing:2026-10-28:d5658bbd83Wed, 28 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: short interest 4,917,178 shares at the 15 October 2026 settlement, 7.28 days to coverhttps://greeksoup.ai/stocks/us/clb/short-interest/us:CLB:short-interest:2026-10-15:04ed67d9e4Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: short interest 4,868,011 shares at the 30 September 2026 settlement, 6.81 days to coverhttps://greeksoup.ai/stocks/us/clb/short-interest/us:CLB:short-interest:2026-09-30:55b612539eWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: short interest 4,382,706 shares at the 15 September 2026 settlement, 10.24 days to coverhttps://greeksoup.ai/stocks/us/clb/short-interest/us:CLB:short-interest:2026-09-15:e32e6be089Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: short interest 4,095,677 shares at the 31 August 2026 settlement, 9.59 days to coverhttps://greeksoup.ai/stocks/us/clb/short-interest/us:CLB:short-interest:2026-08-31:34e9d5f9d6Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Core Laboratories Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/clb/filings/us:CLB:filing:2026-08-25:70a9f5bd2cTue, 25 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: Schedule 13G/A filed by DISCIPLINED GROWTH INVESTORS INC /MN, 6.6% of the classhttps://greeksoup.ai/stocks/us/clb/holders/us:CLB:schedule-13:2026-08-14:ab43c8b65bFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: Schedule 13G/A filed by Ariel Investments, LLC, 30.5% of the classhttps://greeksoup.ai/stocks/us/clb/holders/us:CLB:schedule-13:2026-08-14:6428f3462fFri, 14 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: short interest 4,255,516 shares at the 14 August 2026 settlement, 7.24 days to coverhttps://greeksoup.ai/stocks/us/clb/short-interest/us:CLB:short-interest:2026-08-14:b447bda470Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: Schedule 13G/A filed by BlackRock, Inc., 8.3% of the classhttps://greeksoup.ai/stocks/us/clb/holders/us:CLB:schedule-13:2026-08-06:4be9f100ebThu, 06 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Core Laboratories Inc.: Bruno Lawrence (Chairman and CEO) bought 5,000 shares at $10.78 on 31 July 2026, $53,900https://greeksoup.ai/stocks/us/clb/insiders/us:CLB:insider:2026-08-04:26452a9891Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]>